Five years ago, while investors piled into tech darlings and meme stocks, $1,000 quietly invested in Hawkins Inc (NASDAQ: HWKN) would be worth $5,840 today. That’s a 484% return from a Roseville, Minnesota company that blends specialty chemicals and water treatment solutions. No viral products. No celebrity CEO. Just steady execution in an industry most people find boring.
The Unsexy Path to 484% Returns
Hawkins operates 64 facilities across 28 states, serving industries that need reliable chemistry: water treatment plants, food manufacturers, industrial operations. The business model is straightforward. Buy chemicals in bulk, blend them to customer specifications, deliver with technical support. It’s not disruptive. It’s essential.
The five-year journey started from a foundation of recovery. In fiscal 2018, the company posted a $9.2 million loss. Management regrouped, tightened operations, and returned to profitability by 2019. By fiscal 2021, revenue was $597 million with $41 million in net income. Four years later, those numbers hit $974 million and $84 million respectively. Revenue grew 63%, but earnings doubled. That’s margin expansion, not just scaling.
What drove it? Three things. First, water infrastructure spending accelerated nationwide. Aging systems needed upgrades, and Hawkins positioned itself as the go-to supplier. Second, strategic acquisitions. The company bought WaterSurplus, StillWaters Technology, and Redbird Chemical, expanding its water treatment footprint across the southern U.S. Third, operational discipline. Gross margins improved from 20.7% to 23.1% over the period, showing pricing power in a commodity-adjacent business.
The S&P 500 returned 83% over the same five years. Hawkins beat it by 6x.
Recent Stumbles and the Market’s Doubt
The stock is down 3.3% over the past week and trading 18% below its 52-week high of $186. In October, the company missed earnings estimates, posting $1.08 per share against a $1.23 consensus. Revenue came in at $280 million versus $284 million expected. The stock dropped 15% that week.
But here’s what analysts noticed: despite the miss, they raised the 2026 price target to $166 and reaffirmed revenue growth of 4.2% to $1.09 billion. The Water Treatment segment grew 21% year-over-year in Q2. The company reduced debt by $20 million during the quarter. CEO Patrick Hawkins guided for continued growth in Water Treatment and Industrial Solutions, acknowledging only that Food and Health Sciences faces competitive pressure.
The market is pricing in concern. The fundamentals say otherwise. Earnings are January 28. That’s the test.
Would I Buy It Here?
I’d put $1,000 into Hawkins today if you believe water infrastructure spending continues and the company can maintain its 12% operating margins through acquisition integration. The P/E of 38x looks steep, but that’s what quality costs when institutional ownership sits at 78% and insiders keep buying.
I’d avoid it if you think the Food segment headwinds spread to other divisions or if you need immediate catalysts. This is a compounder, not a lottery ticket.
The lesson from the past five years is clear: boring businesses with pricing power and competent management beat hype every time. Hawkins proved it while nobody was watching.
Top Gaining Stocks
Top Losing Stocks